Long GV, Lipson EJ, Hodi FS, Ascierto PA, et al. First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data. J Clin Oncol 2024 Aug 13:JCO2401125. doi: 10.1200/JCO.24.01125.
PMID: 39137386